Sign In
test

Steve Giordano

Casdin Capital, Llc

Assets Managed
$1.321B
Holdings
40
Last Quarter
2026 - Q1
Filed Date
1mo ago
Growth Rate
-17.97%(2Q avg: 8.14%)
Sustained Growth
0 quarters

Portfolio positions

This chart displays the top 10 holdings in Casdin Capital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 40 positions.

Assets under management

The assets under management (AUM) of Casdin Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.321B in assets, with a quarterly growth rate of -17.97% and a 2-quarter average growth rate of 8.14%. The portfolio is managed by Steve Giordano, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
RVMD
Revolution Medicines Inc
Recent Activity
18.98%
$250.646M
2.577M shares@ $97.25 avg price
WGS
Genedx Holdings Corp
Recent Activity
14.63%
$193.12M
3.007M shares@ $64.22 avg price
RLAY
Relay Therapeutics Inc
Recent Activity
Increased 10.89%
10.87%
$143.465M
14.419M shares@ $9.95 avg price
BLFS
Biolife Solutions Inc
Recent Activity
8.61%
$113.663M
5.957M shares@ $19.08 avg price
LAB
Standard Biotools Inc
Recent Activity
6.19%
$81.619M
88.784M shares@ $0.92 avg price
ILMN
Illumina Inc
Recent Activity
Decreased -11.66%
4.95%
$65.328M
530,000 shares@ $123.26 avg price
GPCR
Structure Therapeutics Inc
Recent Activity
4.29%
$56.635M
1.175M shares@ $48.2 avg price
TXG
10x Genomics Inc-class A
Recent Activity
Increased 62.5%
3.66%
$48.298M
2.275M shares@ $21.23 avg price
DNLI
Denali Therapeutics Inc
Recent Activity
2.68%
$35.328M
1.84M shares@ $19.2 avg price
BEAM
Beam Therapeutics Inc
Recent Activity
Decreased -15.62%
2.44%
$32.171M
1.35M shares@ $23.83 avg price

1-10 of 40